| Differential contribution of spinal mitogen-activated protein kinases to the phase of long-lasting allodynia evoked by intrathecal administration of ATP in rats. | |
| | |
MedLine Citation:
|
PMID: 18520049 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Several lines of evidence suggest that activation of spinal mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK) and p38 MAPK, contributes to the induction and maintenance of chronic pain. We recently reported that an intrathecal (i.t.) administration of ATP evoked tactile allodynia, which lasted more than 1 week in rats. The long-lasting allodynia was induced by activation of spinal P2X 2/3-receptors, and the induction and early phase of maintenance, but not the late phase, was mediated, at least in part, by the activation of spinal glial cells. In this study, we examined the involvement of spinal ERK and p38 MAPK in each phase of i.t. ATP-evoked long-lasting allodynia. I.t. administration of ATP (100 nmol) markedly increased phosphorylated ERK, which peaked at 1-8 h before gradually decreasing to a level that was sustained until 7 d after administration. In contrast, only a slight increase in phosphorylated p38 MAPK was observed. Consistent with the increased phosphorylation of MAPKs, the ERK kinase MEK inhibitor, U0126 (3 nmol), attenuated the induction phase (co-administration with ATP) and early maintenance phase (1-d post-ATP administration) of the i.t. ATP-evoked allodynia, but not the late maintenance phase (7-d post-ATP administration), while the p38 MAPK inhibitor, SB203580 (10 microg), had little effect. These results suggest that the induction phase and early maintenance phase, but not the late maintenance phase of long-lasting allodynia is mediated by the activation of ERK, rather than by the activation of p38 MAPK, in the spinal cord. These findings are informative for elucidating the mechanisms underlying the pathogenesis of chronic pain. |
| | |
Authors:
|
Takayuki Nakagawa; Kayo Wakamatsu; Sanae Maeda; Hisashi Shirakawa; Shuji Kaneko |
Related Documents
:
|
11375349 - The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both glut4 t... 10838079 - Distinct carboxy-termini confer divergent characteristics to the mitogen-activated prot... 15044949 - Gadd45beta/gadd45gamma and mekk4 comprise a genetic pathway mediating stat4-independent... 20626959 - Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats. 12917629 - Overexpression of erbb2 enhances ethanol-stimulated intracellular signaling and invasio... 20717929 - Regulation of udp-glucose dehydrogenase is sufficient to modulate hyaluronan production... 18626479 - Proteolytically active allergens cause barrier breakdown. 2849929 - Protein kinase c activities are increased in rat thyroid epithelial cells expressing v-... 17210649 - Pag-associated fynt regulates calcium signaling and promotes anergy in t lymphocytes. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Biological & pharmaceutical bulletin Volume: 31 ISSN: 0918-6158 ISO Abbreviation: Biol. Pharm. Bull. Publication Date: 2008 Jun |
Date Detail:
|
Created Date: 2008-06-03 Completed Date: 2008-06-30 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 9311984 Medline TA: Biol Pharm Bull Country: Japan |
Other Details:
|
Languages: eng Pagination: 1164-8 Citation Subset: IM |
Affiliation:
|
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan. tnakaga@pharm.kyoto-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine Triphosphate*
/
administration & dosage Animals Blotting, Western Butadienes / pharmacology Enzyme Activation / physiology Enzyme Inhibitors / pharmacology Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors, metabolism Imidazoles / pharmacology Injections, Spinal Male Mitogen-Activated Protein Kinases / antagonists & inhibitors, metabolism* Nitriles / pharmacology Pain / chemically induced*, enzymology* Pain Measurement / drug effects Phosphorylation Pyridines / pharmacology Rats Rats, Sprague-Dawley Spinal Cord / enzymology* p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Butadienes; 0/Enzyme Inhibitors; 0/Imidazoles; 0/Nitriles; 0/Pyridines; 0/SB 203580; 0/U 0126; 56-65-5/Adenosine Triphosphate; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases; EC 2.7.11.24/Mitogen-Activated Protein Kinases; EC 2.7.11.24/p38 Mitogen-Activated Protein Kinases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in establi...
Next Document: Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in dia...